X0508 4 2024-01-10 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001856371 Scanlan Sean F. C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 0 1 0 0 Chief Innovation Officer 0 Common Stock 2024-01-10 4 A 0 65025 0.00 A 97209 D Stock Option (Right to Buy) 13.46 2024-01-10 4 A 0 73200 0.00 A 2034-01-10 Stock Option (Right to Buy) 73200 73200 D Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. Includes 96,070 RSUs. The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date. /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan 2024-01-12